Landscape Capital Management L.L.C. Buys New Holdings in Mirion Technologies, Inc. (NYSE:MIR)

Landscape Capital Management L.L.C. bought a new stake in Mirion Technologies, Inc. (NYSE:MIR) during the 3rd quarter, Holdings Channel reports. The firm bought 13,251 shares of the company’s stock, valued at approximately $147,000.

Several other large investors have also bought and sold shares of MIR. Innealta Capital LLC acquired a new position in Mirion Technologies during the 2nd quarter worth approximately $39,000. Quest Partners LLC increased its holdings in shares of Mirion Technologies by 680.5% during the third quarter. Quest Partners LLC now owns 6,728 shares of the company’s stock worth $74,000 after buying an additional 5,866 shares in the last quarter. Integrated Advisors Network LLC bought a new position in shares of Mirion Technologies in the 3rd quarter valued at $120,000. Algert Global LLC acquired a new stake in shares of Mirion Technologies during the 2nd quarter valued at $189,000. Finally, Bayesian Capital Management LP bought a new stake in Mirion Technologies during the 1st quarter worth $226,000. 78.51% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MIR has been the topic of a number of recent research reports. B. Riley initiated coverage on Mirion Technologies in a research note on Thursday, September 26th. They set a “buy” rating and a $14.00 price target on the stock. Citigroup lifted their target price on shares of Mirion Technologies from $17.00 to $18.00 and gave the stock a “buy” rating in a research report on Thursday, October 31st. Finally, The Goldman Sachs Group upped their price target on shares of Mirion Technologies from $13.00 to $16.00 and gave the company a “buy” rating in a research report on Thursday, October 31st.

Insider Transactions at Mirion Technologies

In other Mirion Technologies news, insider Emmanuelle Lee sold 3,405 shares of the business’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $14.27, for a total value of $48,589.35. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Thomas D. Logan sold 7,500 shares of the stock in a transaction that occurred on Tuesday, September 24th. The stock was sold at an average price of $10.47, for a total value of $78,525.00. Following the transaction, the chief executive officer now owns 1,544,017 shares in the company, valued at $16,165,857.99. The trade was a 0.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,405 shares of company stock worth $285,939 over the last three months. 2.20% of the stock is owned by company insiders.

Mirion Technologies Trading Down 1.1 %

NYSE MIR opened at $16.60 on Tuesday. Mirion Technologies, Inc. has a 12 month low of $8.65 and a 12 month high of $17.03. The company has a current ratio of 2.16, a quick ratio of 1.55 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $3.86 billion, a PE ratio of -48.82 and a beta of 0.73. The business’s 50-day moving average price is $13.39 and its two-hundred day moving average price is $11.54.

Mirion Technologies (NYSE:MIR) last announced its earnings results on Tuesday, October 29th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.02). The company had revenue of $206.80 million during the quarter, compared to the consensus estimate of $203.67 million. Mirion Technologies had a negative net margin of 7.84% and a positive return on equity of 4.33%. The business’s revenue was up 8.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.03 earnings per share. On average, analysts expect that Mirion Technologies, Inc. will post 0.36 EPS for the current year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.